Australian pharmaceutical company with a world first over the counter treatment for heart disease. Coming announcement from the Trump Administration will see our exports to the USA increase from $7 million in 2024 to over $600 million in 2025. We are in the process of establishing a larger manufacturing facility to increase our production capacity.
To help fund this expansion, we are offering a rare opportunity to become a shareholder in this exciting company.
We are offering shares in our company at $100,000 per 1% share. As a shareholder you will own a percentage of the company and will receive quarterly dividends of sales. Share value expected to increase over 800% within the next 10 months. Dividends from sales expected to be around $1 million per share by Christmas.
This is a once in a lifetime opportunity. There are only 10 shares on offer.
Singapore
